This is a $396,190 firm fixed price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Tetraimaging LLC, a small disadvantaged business, to develop ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract was awarded on September 16, 2022 and is set to complete by December 15, 2023. The original solicitation, PHS-2022-1, announced by the NIH and CDC, sought small business...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
This $397,626 Firm Fixed Price contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Standard Imaging Inc., a small business manufacturer of radiation measurement equipment and software headquartered in Middleton, Wisconsin. The award is for the development of "A Novel Scintillation Detector System for Flash Radiation Therapy" under the NCI's Small Business Innovation Research (SBIR) program. This SBIR contract...
This is a Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Tetraimaging LLC, a self-certified small disadvantaged business. The contract, valued at $1,999,930.00, is for the development of a multilayer strip ion chamber device to measure flash-RT beams under the SBIR (Small Business Innovation Research) Program Phase II. The period of performance is from September 16, 2024, to September 15, 2026, and the contract has a total small...
This is a $454,997 fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Ambay Immune Sensors And Controls, LLC, a woman-owned small business. The contract was awarded under the FY20 SBIR Phase I solicitation and is for the development of a "non-invasive, novel test to monitor biological response to radiotherapy" under Topic #400 - AMBAY RADI-SENSE. The contract...
The National Cancer Institute (NCI) has awarded a $1,222,441.00 Firm Fixed Price SBIR Phase II contract to Standard Imaging Inc., a small business manufacturer of specialized radiation measurement equipment and software. The contract, identified as 75N91024C00097, is for the development of a "Novel NIST Traceable Ionization Chamber for Flash Dosimetry" under SBIR Topic No. 434. This contract, set aside for small businesses, aims to advance the field of radiation measurement and therapy...
This is a $1,980,915.00 firm-fixed-price SBIR Phase II contract awarded by the National Cancer Institute (part of the Department of Health and Human Services) to Pyramid Technical Consultants, Inc., a for-profit manufacturing company, for the development of ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract has a period of performance from September 16, 2024 to September 15, 2026 and is set aside for a small business. The contract was awarded under SBIR Topic 434...
This $2,399,183 firm-fixed-price SBIR Phase I contract was awarded by the National Cancer Institute (NCI) to Radiologics, Inc., a small business, to conduct research and development on cancer imaging tools and image de-identification software. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase private sector commercialization of innovations derived from federal R&D. The contract has a period of performance through January 2024 and is...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader...
The National Cancer Institute awarded a $399,504 Small Business Innovation Research (SBIR) Phase I contract to Standard Imaging Inc., a small business manufacturer of radiation measurement equipment and software, for the development of a novel NIST-traceable ionization chamber for flash dosimetry. This award is related to SBIR Topic 434 from a broader NIH/CDC SBIR solicitation focused on advancing research and development to support the agencies' infectious disease, cancer, aging, and public...